Literature DB >> 2226778

Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxin.

L Mantovani1, R Henschler, M A Brach, R Wieser, M Lübbert, A Lindemann, R H Mertelsmann, F Herrmann.   

Abstract

The treatment of human diploid fibroblasts with tumor necrosis factor (TNF)-alpha and with lymphotoxin (LT) is associated with induction of interleukin-6 (IL-6) transcripts with TNF-alpha being 10-fold more potent than LT. Here we report on the TNF-alpha/LT-induced signaling mechanisms responsible for the regulation of IL-6 gene expression in these cells. Run-on assays demonstrated that both TNF-alpha and LT increase IL-6 mRNA levels by transcriptional activation of this gene. Stability studies of IL-6 transcripts in fibroblasts showed that TNF-alpha delayed IL-6 mRNA decay but not LT. The induction of IL-6 transcripts by TNF-alpha and LT was not inhibited by the isoquinoline sulfonamide derivative H7. Similarly, depletion of protein kinase C (PKC) by 12-O-tetradecanoyl-phorbol 13-acetate (TPA) did not change the ability of TNF-alpha and LT to induce IL-6 transcripts, demonstrating that stimulation by these agents may not be mediated by activation of PKC. Stimulation of IL-6 transcripts in fibroblasts did also not require new protein synthesis as exposure to the protein synthesis inhibitor cycloheximide (CHX) enhanced accumulation of IL-6 mRNA in the presence or absence of TNF-alpha or LT.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226778     DOI: 10.1016/0014-5793(90)81256-n

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

Review 1.  Production of interleukin-6 by synovial fibroblasts in rheumatoid arthritis.

Authors:  H Baumann; I Kushner
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

2.  The mitogenic response to tumor necrosis factor alpha requires c-Jun/AP-1.

Authors:  M A Brach; H J Gruss; C Sott; F Herrmann
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

Review 3.  Interleukin-6 in clinical medicine.

Authors:  J Bauer; F Herrmann
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

4.  Autocrine tumor necrosis factor (TNF) and lymphotoxin (LT) alpha differentially modulate cellular sensitivity to TNF/LT-alpha cytotoxicity in L929 cells.

Authors:  E Decoster; S Cornelis; B Vanhaesebroeck; W Fiers
Journal:  J Cell Biol       Date:  1998-12-28       Impact factor: 10.539

5.  Identification of NF-jun, a novel inducible transcription factor that regulates c-jun gene transcription.

Authors:  M A Brach; F Herrmann; H Yamada; P A Bäuerle; D W Kufe
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

6.  Tumor necrosis factor (TNF)-alpha activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase.

Authors:  C Belka; K Wiegmann; D Adam; R Holland; M Neuloh; F Herrmann; M Krönke; M A Brach
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

7.  Growth arrest of the breast cancer cell line, T47D, by TNF alpha; cell cycle specificity and signal transduction.

Authors:  L Pusztai; C E Lewis; J O McGee
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.